الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 139 |  |  |
| | | from | 139 | | |
Abstract
Benign prostatic hyperplasia (BPH) is the most common benign neoplasm in men. And the incidence increases with increasing age. Although not a life-threatening condition, BPH can significantly affect quality of life.
LUTS can be brought by the static component of BPH; the increased prostatic mass compresses and inhibits urinary flow. LUTS also can arise throughout the dynamic component of BPH; increased smooth muscle tone in the prostate and prostatic urethra by stimulation of alpha adrenoreceptors in the lower urinary tract.
Since medical therapy offers an attractive alternative to surgery, the number of transurethral resections of the prostate has declined and 5α-reductase inhibitors, α-blockers and phytotherapeutic agents are assuming increasing importance in the treatment of LUTS.